ArticleInsights into imaging2026

MRI-based quantification of intratumoral heterogeneity for predicting recurrence risk in ER+/HER2- breast cancer.

Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.